Single-nucleotide polymorphisms in dizygotic twin ovine fetuses are associated with discordant responses to antenatal steroid therapy
Authors:
Open Access
- 4 February 2025
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 23 (1) , 1-17
Abstract
Background: Antenatal steroid (ANS) therapy is given to women at risk of preterm delivery to accelerate fetal lung maturation. However, the benefit of ANS therapy is variable and how maternal and fetal factors contribute to this observed variability is unknown. We aimed to test the degree of concordance in preterm lung function, and correlate this with genomic, transcriptomic, and pharmacokinetic variables in preterm dizygotic twin ovine fetuses. Methods: Thirty-one date-mated ewes carrying twin fetuses at 123 ± 1 days’ gestation received maternal intramuscular injections of either (i) 1 × 0.25 mg/kg betamethasone phosphate and acetate (CS1, n = 11 twin pairs) or (ii) 2 × 0.25 mg/kg betamethasone phosphate and acetate, 24 h apart (CS2, n = 10 twin pairs) or (iii) 2 × saline, 24 h apart (negative control, n = 10 twin pairs). Fetuses were surgically delivered 24 h after their final treatment and ventilated for 30 min. Results: ANS-exposed female fetuses had lower arterial partial pressure of carbon dioxide (PaCO2) values than male fetuses (76.5 ± 38.0 vs. 97.2 ± 42.5 mmHg), although the observed difference was not statistically significant (p = 0.1). Only 52% of ANS-treated twins were concordant for lung maturation responses. There was no difference in fetal lung tissue or plasma steroid concentrations within or between twin pairs. Genomic analysis identified 13 single-nucleotide polymorphisms (SNPs) statistically associated with ANS-responsiveness, including in the proto-oncogene MET and the transcription activator STAT1. Conclusions: Twin fetal responses and ANS tissue levels were comparable with those from singleton fetuses in earlier studies. Twin ovine fetuses thus benefit from ANS in a similar manner to singleton fetuses, and a larger dose of betamethasone is not required. Assuming no difference in input from the placental or maternal compartments, fetal lung responses to ANS therapy in dizygotic twin preterm lambs are dependent on the fetus itself. These data suggest a potential heritable role in determining ANS responsiveness.Keywords
This publication has 65 references indexed in Scilit:
- Antenatal Corticosteroid Treatment During the Late-Preterm Period and Neonatal Outcomes for Twin PregnanciesJAMA Network Open, 2023
- Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birthCochrane Database of Systematic Reviews, 2020
- Does antenatal steroids treatment in twin pregnancies prior to late preterm birth reduce neonatal morbidity? Evidence from a retrospective cohort studyArchives of Gynecology and Obstetrics, 2020
- IDO1 Maintains Pluripotency of Primed Human Embryonic Stem Cells by Promoting GlycolysisStem Cells, 2019
- Maternofetal pharmacokinetics and fetal lung responses in chronically catheterized sheep receiving constant, low-dose infusions of betamethasone phosphateAmerican Journal of Obstetrics and Gynecology, 2016
- The role of antenatal corticosteroids in twin pregnancies complicated by preterm birthAmerican Journal of Obstetrics and Gynecology, 2016
- The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid useAmerican Journal of Obstetrics and Gynecology, 2012
- The role of functional single nucleotide polymorphisms of the human glucocorticoid receptor gene NR3C1 in Polish patients with bronchial asthmaMolecular Biology Reports, 2011
- Betamethasone in pregnancy: influence of maternal body weight and multiple gestation on pharmacokineticsAmerican Journal of Obstetrics and Gynecology, 2010
- Scientific basis and therapeutic regimens for use of antenatal glucocorticoidsAmerican Journal of Obstetrics and Gynecology, 1995